Live News REGULATION FLASH L impact Nov 16, 2026, 06:00 AM UTC FDA Approves Roche’s Gazyva for Primary Membranous Nephropathy Gazyva/Gazyvaro becomes the first FDA-approved treatment for primary membranous nephropathy. SquawkNews Desk